The Potential Economic Benefits of Improved Postfracture Care: A Cost-Effectiveness Analysis of a Fracture Liaison Service in the US Health-Care System

Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

(2013) Patrick Haentjens   ANNALS OF INTERNAL MEDICINE

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis

(2013) Lydia Gedmintas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of the jaw

(2013) MS Najm et al.   ORAL DISEASES

Secondary prevention of osteoporotic fractures—an “OPTIMAL” model of care from Singapore

(2013) M. Chandran et al.   OSTEOPOROSIS INTERNATIONAL

Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention

(2012) John A Eisman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges

(2012) D. H. Solomon et al.   OSTEOPOROSIS INTERNATIONAL

The Economics of Improving Medication Adherence in Osteoporosis: Validation and Application of a Simulation Model

(2011) Amanda R. Patrick et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Quality of Life Implications of Bisphosphonate-Associated Osteonecrosis of the Jaw

(2011) R. A. Miksad et al.   ONCOLOGIST

Fracture prevention in Kaiser Permanente Southern California

(2011) R. Dell   OSTEOPOROSIS INTERNATIONAL

Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision

(2011) A. R. McLellan et al.   OSTEOPOROSIS INTERNATIONAL

The Complex Relation between Bisphosphonate Adherence and Fracture Reduction

(2010) Amanda R. Patrick et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US

(2010) C. T. Pike et al.   OSTEOPOROSIS INTERNATIONAL

Safety of Bisphosphonates in the Treatment of Osteoporosis

(2009) Robert R. Recker et al.   AMERICAN JOURNAL OF MEDICINE

Osteoporosis Case Manager for Patients With Hip Fractures

(2009) Sumit R. Majumdar et al.   ARCHIVES OF INTERNAL MEDICINE

Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study

(2009) Jonathan D. Adachi et al.   CLINICAL THERAPEUTICS

The American Orthopaedic Associationʼs “Own the Bone” Initiative to Prevent Secondary Fractures

(2008) Laura L Tosi et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Long-Term Survival and Fracture Risk After Hip Fracture: A 22-Year Follow-Up in Women

(2008) My von Friesendorff et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Does a History of Non-Vertebral Fracture Identify Women Without Osteoporosis for Treatment?

(2008) Kathryn M. Ryder et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Incorporating adherence into health economic modelling of osteoporosis

(2008) O. Ström et al.   OSTEOPOROSIS INTERNATIONAL